These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32794429)

  • 21. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.
    Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB
    J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
    Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
    Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single Center experience.
    Putnik S; Terzić D; Nestorović E; Karan R; Dobri M; Andrijasević V; Zlatkovic M; Kostić NK; Velinovic M; Ivanisevic D; Ristić M
    Ann Ital Chir; 2020; 91():8-15. PubMed ID: 32180572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure and adverse events during continuous flow left ventricular assist device support.
    Saeed O; Jermyn R; Kargoli F; Madan S; Mannem S; Gunda S; Nucci C; Farooqui S; Hassan S; Mclarty A; Bloom M; Zolty R; Shin J; D'Alessandro D; Goldstein DJ; Patel SR
    Circ Heart Fail; 2015 May; 8(3):551-6. PubMed ID: 25870369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Age on Outcomes After Destination-Therapy Left Ventricular Assist Device Implantation: An Analysis of the IMACS Registry.
    Aleksova N; Alba AC; Fan CS; Amin F; Kiamanesh O; McGuinty C; Lee H; Duero Posada JG; Ross HJ; Billia F; Rao V
    Can J Cardiol; 2021 Mar; 37(3):467-475. PubMed ID: 32585330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding Left Ventricular Assist Devices.
    Aissaoui N; Jouan J; Gourjault M; Diebold B; Ortuno S; Hamdan A; Latremouille C; Pirracchio R; Morshuis M
    Blood Purif; 2018; 46(4):292-300. PubMed ID: 30048974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of Preoperative Existence of Atrial Fibrillation on Hemocompatibility-Related Adverse Events During Left Ventricular Assist Device Support.
    Imamura T; Kinugawa K; Ono M; Kinoshita O; Fukushima N; Shiose A; Matsui Y; Yamazaki K; Saiki Y; Usui A; Niinami H; Matsumiya G; Arai H; Sawa Y
    Circ J; 2019 May; 83(6):1286-1292. PubMed ID: 31019163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil to Lymphocyte Ratio Is Related to Thrombotic Complications and Survival in Continuous Flow Left Ventricular Assist Devices.
    Ferrera C; Gonzalez Fernandez O; Bouzas N; Castrodeza J; Green T; Woods A; Robinson-Smith N; Tovey S; Jakovljevic DG; Shah A; Booth K; Parry G; Schueler S; MacGowan GA
    ASAIO J; 2020 Feb; 66(2):199-204. PubMed ID: 30913104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From bench to bedside: Can the improvements in left ventricular assist device design mitigate adverse events and increase survival?
    Tarzia V; Di Giammarco G; Di Mauro M; Bortolussi G; Maccherini M; Tursi V; Maiani M; Bernazzali S; Marinelli D; Foschi M; Buratto E; Bejko J; Gregori D; Scuri S; Livi U; Sani G; Bottio T; Gerosa G
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):213-7. PubMed ID: 26548997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device.
    Fudim M; Brown CL; Davis ME; Djunaidi M; Danter MR; Harrell FE; Stulak JM; Haglund NA; Maltais S
    ASAIO J; 2016; 62(3):291-6. PubMed ID: 26809083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection.
    Olmsted RZ; Critsinelis A; Kurihara C; Kawabori M; Sugiura T; Civitello AB; Morgan JA
    J Card Surg; 2019 Feb; 34(2):82-91. PubMed ID: 30710496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.